Using a multidisciplinary team and clinical redesign to improve blood pressure control in patients with diabetes

Quality Management in Health Care

Volumn 17, Issue 3, 2008, Pages 227-233

  Choe, Hae Mi ^a   Bernstein, Steven J ^b,c   Cooke, David ^b   Stutz, David ^b   Standiford, Connie ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Clinical redesign; Diabetes; Hypertension

Indexed keywords

AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 54049110086     PISSN: 10638628     EISSN: 15505154     Source Type: Journal    
DOI: 10.1097/01.QMH.0000326727.01203.99     Document Type: Article

References (26)

1. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
2. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21(2):296-309.
3. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002. Diabetes Care. 2006;29(3):531-537.
4. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes. Ann Intern Med. 2003;138:593-602.
5. United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ. 1998;317(7160):703- 713.
6. HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet. 1998;351:1755-1762.
7. Coffey RM, Matthews TL, McDermott K.Diabetes Care Quality Improvement: A Resource Guide for State Action. (Prepared by The Medstat Group Inc and The Council of State Governments under Contract No. 290-00-0004). Rockville, MD: Agency for Healthcare Research and Quality, Department of Health and Human Services; 2004. AHRQ Pub. No. 04-0072.
8. Hippisley J, O'Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53 000 patients in primary care. BMJ. 2004;329:1267-1269.
9. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
10. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in western Europe and the United States. Arch Intern Med 2007;167:141-147.
11. Wong ND, Lopez VA, Franklin SS. Inadequate controlof hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med. 2007;167(22):2431-2436.
12. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pressure control through provider education, provider alerts, and patient education. Ann Intern Med. 2006;145:165-175.
13. Grant RW, Cagliero RW, Dubey E, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150-155.
14. Barr M, Ginsburg J. The Advanced Medical Home: A Patient-Centered, Physician-Guided Model of Health Care. Philadelphia, PA: American College of Physicians Policy Monograph; 2006.
15. Future of Family Medicine Project Leadership Committee. The future of family medicine. A collaborative project of the Family Medicine Community. Ann Fam Med. 2004;2(suppl 1):S3-S32.
16. Morello CM, Zadvorny EB, Cording MA, Suemoto RT, Skog J, Harari A. Development and clinical outcomes of pharmacistmanaged diabetes care clinics. Am J Health Syst Pharm. 2006;63:1325-1331.
17. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104-1111.
18. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist co-management of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23(2):209-216.
19. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Int Med. 1998;13(11):740-745.
20. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17(1):140-147.
21. Vijan S, Choe HM, Funnell M, et al. Management of Type 2 Diabetes Mellitus. (Update) Ann Arbor, MI: Office of Clinical Affairs, University of Michigan Health System; 2007. www.guideline.gov. NGC-3788. Accessed December 19, 2007.
22. Walsh ME, McDonald KM, Shojania K, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44:646-657.
23. Jha AK, Perlin JB, Kizer KW, Dudley A. Effect of the transformation of the veterans affairs health care system on the quality of care. N Eng J Med. 2003;348(22):2218-2227.
24. Jamtvedt G, Young JM, Krisoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effect on professional practice and health care outcomes. Cochrane Database Syst Rev. 2003(3):CD000259.
25. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-834.
26. Ostbye T, Yarnall KSH, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005;3:209-214.